share_log
Benzinga ·  Jul 22 08:18
MIRA Pharmaceuticals Shares Are Trading Higher After the Company Announced New Preclinical Study Results for Its Novel Oral Ketamine Analog, Ketamir-2
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment